Effect of aromatherapy and breathing relaxation on anxiety and vital signs
- Conditions
- Anxiety.
- Registration Number
- IRCT20190518043618N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
The patient's caretaker must voluntarily sign an informed consent form for participation in the study.
The patient should have a known diagnosis of depression.
The patient should score higher than 7 from the Beck Anxiety Inventory.
The patient should be referred for the first session of electroconvulsive therapy.
The patient should have the ability to speak and understand Persian language.
Having any physical illness that leads to cognitive impairment.
Having a history of known anxiety disease
Use of anxiolytic drugs 24 hours before the intervention
Having a history of drug abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of patients whose anxiety scores are higher than 7 measured by Beck's anxiety inventory. Timepoint: Anxiety is measured before intervention and then 30 minutes after intervention. Method of measurement: Beck Anxiety Inventory.;Respiratory rate. Timepoint: Before intervention and then 30 minutes after intervention. Method of measurement: Counting the patient's respiratory rate for 1 minutes.;Blood pressure. Timepoint: Before intervention and then 30 minutes after intervention. Method of measurement: A mercury sphygmomanometer.;Heart rate. Timepoint: Before intervention and then 30 minutes after intervention. Method of measurement: Reading HR from pulse oximetry attached to patient's finger.;Arterial oxygen saturation (SaO2 %). Timepoint: Before intervention and then 30 minutes after intervention. Method of measurement: Reading SiO2 from pulse oximetry device attached to patient's finger.
- Secondary Outcome Measures
Name Time Method